Adalimumab-Adaz

Common brands: Humira, Adalimumab, Methotrexate, Trexall, Rasuvo

Top reporter: Cordavis Limited

Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Aminosalicylate [EPC]
49,781
Total Reports
37,567
Serious Reports
7,435
Death Reports
30
Reported Reactions
Death Report Ratio: High (14.94%)

Patient Demographics

Male
13,013
Female
26,445

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Adalimumab-Adaz.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 10,987
7.8%
2 OFF LABEL USE 8,833
6.3%
3 PAIN 6,014
4.3%
4 FATIGUE 6,002
4.3%
5 RHEUMATOID ARTHRITIS 5,989
4.3%
6 ARTHRALGIA 5,822
4.2%
7 RASH 4,906
3.5%
8 CONDITION AGGRAVATED 4,683
3.3%
9 DIARRHOEA 4,519
3.2%
10 DRUG INTOLERANCE 4,413
3.2%
11 NAUSEA 4,313
3.1%
12 SYSTEMIC LUPUS ERYTHEMATOSUS 4,291
3.1%
13 HEADACHE 4,276
3.1%
14 JOINT SWELLING 4,274
3.1%
15 ALOPECIA 4,099
2.9%
16 ABDOMINAL DISCOMFORT 4,052
2.9%
17 PSORIATIC ARTHROPATHY 4,043
2.9%
18 SYNOVITIS 4,013
2.9%
19 TREATMENT FAILURE 3,947
2.8%
20 GENERAL PHYSICAL HEALTH DETERIORATION 3,904
2.8%
21 MALAISE 3,881
2.8%
22 ARTHROPATHY 3,842
2.7%
23 GLOSSODYNIA 3,840
2.7%
24 PEMPHIGUS 3,741
2.7%
25 INFUSION RELATED REACTION 3,642
2.6%
26 SWELLING 3,627
2.6%
27 HAND DEFORMITY 3,603
2.6%
28 VOMITING 3,520
2.5%
29 WOUND 3,497
2.5%
30 HYPERTENSION 3,435
2.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.